Investigation Overview
December 18, 2013 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of NuPathe Inc (NASDAQ:PATH) shares, was announced concerning whether the takeover of NuPathe Inc by Endo Health Solutions for $3.15 per share is unfair to NASDAQ:PATH stockholders. The investigation by a law firm concerns whether certain officers and directors of NuPathe ...
You must register (for free) or login to view the entire investigation.